Decisions about add-on reimbursement for medical devices in France in October 2019

22

Nov 2019

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in October 2019.

Seven (7) decision was released regarding orthopedic devices:

  • BIOBANK, viro-inactivated bone allograft by SUPERCRIT process (renewal of registration, approved)
  • CAPITOL - EVIDENCE (to cement), dual mobility acetabulum consisting of a cemented cup and a conventional polyethylene insert (application for registration, approved)
  • CAPTIV DM - EVIDENCE Ti / HAC, dual mobility acetabulum consisting of an uncemented cup and a conventional polyethylene insert (application for registration, approved)
  • CAPITOL I - CAPITOL R - EVIDENCE Ti / HAC REVISION, dual mobility acetabulum consisting of an uncemented cup and a conventional polyethylene insert (application for registration, approved)
  • CAPITOL U, dual mobility acetabulum consisting of an uncemented cup and a conventional polyethylene insert (application for registration, rejected because the value has not been demonstrated)
  • ROTATOR 4R57, rotation adapter for external transfemoral prosthesis  (application to change the registration conditions + renewal; approved)
  • ROTATOR 4R57 = WR, rotation adapter for external transfemoral prosthesis (application for registration, approved)

Seven (7) decisions were released for cardiovascular devices:

  • PERCEPTA QUAD CRT-P SURESCAN MRI, implantable cardiac pacemaker with atrio-biventricular stimulation for resynchronization called "triple chamber" associated with carelink telemonitoring system (application to change the registration conditions, approved)
  • percepta crt-p mri surescan, implantable cardiac pacemaker with atrio-biventricular stimulation for resynchronization called "triple chamber" associated with CARELINK telemonitoring system (application to change the registration conditions, approved)
  • AZURE XT SR MRI SURESCAN, Single-Frequency Rate Implantable Cardiac Pacemaker Combined with CARELINK Remote Monitoring System (application to change the registration conditions, approved)
  • AZURE XT DR MRI SURESCAN, double-chamber implantable cardiac pacemaker associated with the CARELINK telemonitoring system (application to change the registration conditions, approved)
  • SAPIEN 3 ™ EDWARDS SYSTEM (CERTITUDE), aortic valve bioprosthesis implanted transapically (CERTITUDE system) (application to change the registration conditions, approved)
  • SAPIEN 3 ™ EDWARDS SYSTEM (COMMANDER), aortic valve bioprosthesis implanted transapically (COMMANDER system) (application to change the registration conditions, approved)
  • NAVVUS CATHETER, rapid exchange system for measuring the fraction of the coronary reserve flow (FFR) (application for registration, rejected because the provided data do not establish the interest)
  • ZENITH t-Branch (standard), thoracoabdominal  stent (application for registration, approved)

Ten (10) decisions were released for other devices:

  • TENOLIG, percutaneous suture implant of the Achilles tendon (renewal of registration, approved)
  • NINO ONE, electric motorized wheel assisting the driving of a manual wheelchair (application for registration, rejected because the value has not been demonstrated)
  • Cochlear Implant Systems: MI1250 SYNCHRONY 2 and MI1250 SYNCHRONY 2 PIN, Cochlear Implants - SONNET 2 ME1510 and SONNET 2 EAS ME1520, Sound Processors (application for registration, approved)
  • ALBER E-PILOT, traction device with electric drive for manual wheelchair user (application for registration, rejected because the value has not been demonstrated)
  • OPUR (bladder hammock kit), bladder retaining implant for transvaginal genitourinary prolapse cure (application for registration, rejected because the value has not been demonstrated)
  • AXONICS SNM SYSTEM, rechargeable neuromodulator of sacred roots (application for registration, approved)
  • MINIMED SYSTEM 640G, interstitial glucose continuous measurement system coupled to an external insulin pump (application to change the registration conditions, approved)
  • PERISTEEN TRANSANAL IRRIGATION system (application to change the registration conditions + renewal; approved)
  • GLUCOFIX TECH 2K and GLUCOFIX TECH B-KETONE SENSOR, apparatus for automatic coded reading of blood glucose and ketones and associated test strips for measuring ketones (application for registration, approved)
  • NATPAR PEN, NATPAR parathyroid hormone cartridge injector pen (application for registration, approved)

See the list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more